Boston Scientific Q2 Adjusted Earnings, Sales Rise; Full-Year Outlook Updated

MT Newswires Live

Jul 23, 2025

Boston Scientific (BSX) reported Q2 adjusted earnings Wednesday of $0.75 per diluted share, up from $0.62 a year earlier.

Analysts polled by FactSet expected $0.73.

Net sales for the quarter ended June 30 were $5.06 billion compared with $4.12 billion a year earlier.

Analysts surveyed by FactSet expected $4.89 billion.

For Q3, the company expects adjusted EPS of $0.70 to $0.72. Analysts are looking for $0.70.

Net sales for the quarter are projected to rise 17% to 19%, according to the company.

For 2025, Boston Scientific said it now expects adjusted EPS of $2.95 to $2.99 versus its prior outlook range of $2.87 to $2.94. Analysts are looking for $2.92.

The company now projects full-year net sales growth at 18% to 19% versus its previous guidance range of 15% to 17%.

Boston Scientific shares were up 1% in recent premarket activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2553214079"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553214079\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553214079?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-23 18:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553214079","market":"fut","top_or_hot":-1,"title":"Boston Scientific Q2 Adjusted Earnings, Sales Rise; Full-Year Outlook Updated","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/BSX\">Boston Scientific</a> (BSX) reported Q2 adjusted earnings Wednesday of $0.75 per diluted share, up from $0.62 a year earlier.</p><p>Analysts polled by FactSet expected $0.73.</p><p>Net sales for the quarter ended June 30 were $5.06 billion compared with $4.12 billion a year earlier.</p><p>Analysts surveyed by FactSet expected $4.89 billion.</p><p>For Q3, the company expects adjusted EPS of $0.70 to $0.72. Analysts are looking for $0.70.</p><p>Net sales for the quarter are projected to rise 17% to 19%, according to the company.</p><p>For 2025, Boston Scientific said it now expects adjusted EPS of $2.95 to $2.99 versus its prior outlook range of $2.87 to $2.94. Analysts are looking for $2.92.</p><p>The company now projects full-year net sales growth at 18% to 19% versus its previous guidance range of 15% to 17%.</p><p>Boston Scientific shares were up 1% in recent premarket activity.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boston Scientific Q2 Adjusted Earnings, Sales Rise; Full-Year Outlook Updated</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoston Scientific Q2 Adjusted Earnings, Sales Rise; Full-Year Outlook Updated\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-23 18:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/BSX\">Boston Scientific</a> (BSX) reported Q2 adjusted earnings Wednesday of $0.75 per diluted share, up from $0.62 a year earlier.</p><p>Analysts polled by FactSet expected $0.73.</p><p>Net sales for the quarter ended June 30 were $5.06 billion compared with $4.12 billion a year earlier.</p><p>Analysts surveyed by FactSet expected $4.89 billion.</p><p>For Q3, the company expects adjusted EPS of $0.70 to $0.72. Analysts are looking for $0.70.</p><p>Net sales for the quarter are projected to rise 17% to 19%, according to the company.</p><p>For 2025, Boston Scientific said it now expects adjusted EPS of $2.95 to $2.99 versus its prior outlook range of $2.87 to $2.94. Analysts are looking for $2.92.</p><p>The company now projects full-year net sales growth at 18% to 19% versus its previous guidance range of 15% to 17%.</p><p>Boston Scientific shares were up 1% in recent premarket activity.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSX","symbol_name":"波士顿科学","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2553214079","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553214079","pubTimestamp":1753268305,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Boston Scientific  reported Q2 adjusted earnings Wednesday of $0.75 per diluted share, up from $0.62 a year earlier.Analysts polled by FactSet expected $0.73.Net sales for the quarter ended June 30 were $5.06 billion compared with $4.12 billion a year earlier.Analysts surveyed by FactSet expected $4.89 billion.For Q3, the company expects adjusted EPS of $0.70 to $0.72. Analysts are looking for $0.70.Net sales for the quarter are projected to rise 17% to 19%, according to the company.For 2025, Boston Scientific said it now expects adjusted EPS of $2.95 to $2.99 versus its prior outlook range of $2.87 to $2.94. Analysts are looking for $2.92.The company now projects full-year net sales growth at 18% to 19% versus its previous guidance range of 15% to 17%.Boston Scientific shares were up 1% in recent premarket activity.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BSX":"波士顿科学"},"translate_title":"波士顿科学第二季度调整后盈利、销售额增长；全年展望更新","themeId":"37b8e66d408164b778e5143f90781f22","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1},"content_text":"Boston Scientific (BSX) reported Q2 adjusted earnings Wednesday of $0.75 per diluted share, up from $0.62 a year earlier.Analysts polled by FactSet expected $0.73.Net sales for the quarter ended June 30 were $5.06 billion compared with $4.12 billion a year earlier.Analysts surveyed by FactSet expected $4.89 billion.For Q3, the company expects adjusted EPS of $0.70 to $0.72. Analysts are looking for $0.70.Net sales for the quarter are projected to rise 17% to 19%, according to the company.For 2025, Boston Scientific said it now expects adjusted EPS of $2.95 to $2.99 versus its prior outlook range of $2.87 to $2.94. Analysts are looking for $2.92.The company now projects full-year net sales growth at 18% to 19% versus its previous guidance range of 15% to 17%.Boston Scientific shares were up 1% in recent premarket activity.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}